Cite
HARVARD Citation
Vollmer, B. et al. (2019). Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment. Annals of clinical and translational neurology. 6 (2), pp. 252-262. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vollmer, B. et al. (2019). Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment. Annals of clinical and translational neurology. 6 (2), pp. 252-262. [Online].